Table 1 Description of the multistep development process
From: Development of the China’s list of ambulatory care sensitive conditions (ACSCs): a study protocol
Steps and sub-steps | Establishment of working groups | Generation of the initial list | Optimization of the list | Approval of the final list version | |||
|---|---|---|---|---|---|---|---|
Review of published lists | Semi-structured interviews | Calculations of hospitalization rate | Evidence evaluation | Delphi consensus survey | |||
Main objective | To identify individuals who are relevant to participant in the project | To develop the initial version of the ACSCs list | To collect and synthesize the evidence of each disease in the ACSCs list | To define the list of diseases to be included in the list | To approve the final version of the list | ||
Study design | – | Scoping review | Semi-structured interviews | Descriptive study | Systematic review | Delphi consensus survey | Face-to-face consensus |
Participants | All participants | Evidence Review Team (6 participants) | Advisory Group (7 participants) | Evidence Review Team (2 participants) | Evidence Review Team (8 participants) | Delphi Panel (21–29 participants) | Advisory Group (7 participants) |
Coordination Team (2 participants) | Coordination Team (2 participants) | Coordination Team (2 participants) | Delphi Panel (21–29 participants) | ||||
Coordination Team (2 participants) | |||||||
Main outcome | Advisory Group (7 participants) | Potential diseases in the published lists | Participants’ views and experiences on ACSCs | The top 30 diseases of hospitalization rates in China | The evidence status of each potential disease in the list | Diseases considered appropriate in China’s list of ACSCs | The final version of China’s list of ACSCs |
Delphi Panel (21–29 participants) | |||||||
Evidence Review Team (8 participants) | |||||||
Coordination Team (2 participants) | |||||||